Janney Montgomery Scott
PBE icon

Janney Montgomery Scott’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Janney Montgomery Scott’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Sell
3,830
-378
-9% -$30.6K ﹤0.01% 2376
2025
Q4 		$346K Sell
4,208
-134
-3% -$10.4K ﹤0.01% 2452
2025
Q3 		$303K Sell
4,342
-738
-15% -$49.9K ﹤0.01% 2495
2025
Q2 		$326K Sell
5,080
-344
-6% -$21.3K ﹤0.01% 2298
2025
Q1 		$344K Buy
5,424
+604
+13% +$40.6K ﹤0.01% 2226
2024
Q4 		$321K Hold
4,820
– – ﹤0.01% 2271
2024
Q3 		$337K Sell
4,820
-907
-16% -$62.8K ﹤0.01% 2223
2024
Q2 		$371K Buy
5,727
+407
+8% +$25.8K ﹤0.01% 2093
2024
Q1 		$344K Sell
5,320
-125
-2% -$8.13K ﹤0.01% 2245
2023
Q4 		$358K Hold
5,445
– – ﹤0.01% 2120
2023
Q3 		$311K Hold
5,445
– – ﹤0.01% 2114
2023
Q2 		$334K Sell
5,445
-50
-0.9% -$3.12K ﹤0.01% 2167
2023
Q1 		$345K Sell
5,495
-760
-12% -$49K ﹤0.01% 1965
2022
Q4 		$397K Sell
6,255
-715
-10% -$45.4K ﹤0.01% 1924
2022
Q3 		$411K Buy
6,970
+350
+5% +$21.6K ﹤0.01% 1814
2022
Q2 		$383K Sell
6,620
-25
-0.4% -$1.44K ﹤0.01% 1755
2022
Q1 		$412K Sell
6,645
-1,120
-14% -$68.3K ﹤0.01% 1735
2021
Q4 		$553K Sell
7,765
-389
-5% -$28.2K ﹤0.01% 1654
2021
Q3 		$610K Hold
8,154
– – ﹤0.01% 1534
2021
Q2 		$631K Buy
8,154
+1,460
+22% +$108K ﹤0.01% 1502
2021
Q1 		$494K Sell
6,694
-1,216
-15% -$92K ﹤0.01% 1565
2020
Q4 		$555K Sell
7,910
-100
-1% -$6.33K ﹤0.01% 1505
2020
Q3 		$454K Sell
8,010
-1,303
-14% -$76.5K ﹤0.01% 1472
2020
Q2 		$543K Hold
9,313
– – ﹤0.01% 1321
2020
Q1 		$433K Sell
9,313
-4,294
-32% -$224K ﹤0.01% 1292
2019
Q4 		$760K Sell
13,607
-222
-2% -$11.6K 0.01% 1217
2019
Q3 		$655K Sell
13,829
-1,810
-12% -$92.8K ﹤0.01% 1233
2019
Q2 		$837K Sell
15,639
-1,926
-11% -$99.9K 0.01% 1140
2019
Q1 		$969K Buy
17,565
+8,478
+93% +$448K 0.01% 1048
2018
Q4 		$428K Buy
9,087
+300
+3% +$15.4K ﹤0.01% 1386
2018
Q3 		$522K Hold
8,787
– – ﹤0.01% 1421
2018
Q2 		$481K Buy
8,787
+750
+9% +$38.1K ﹤0.01% 1412
2018
Q1 		$396K Hold
8,037
– – ﹤0.01% 1454
2017
Q4 		$379K Sell
8,037
-1,920
-19% -$90K ﹤0.01% 1465
2017
Q3 		$497K Buy
9,957
+75
+0.8% +$3.56K 0.01% 1262
2017
Q2 		$451K Buy
9,882
+493
+5% +$21.3K 0.01% 1223
2017
Q1 		$397K Buy
9,389
+196
+2% +$8.22K 0.01% 1272
2016
Q4 		$357K Buy
9,193
+1,372
+18% +$55.4K 0.01% 1229
2016
Q3 		$328K Buy
+7,821
New +$321K 0.01% 1149
2016
Q2 		– Sell
-6,301
Closed -$241K – 1022
2016
Q1 		$241K Sell
6,301
-1,065
-14% -$41.4K 0.01% 1055
2015
Q4 		$372K Sell
7,366
-475
-6% -$23.5K 0.01% 948
2015
Q3 		$358K Sell
7,841
-3,503
-31% -$196K 0.01% 978
2015
Q2 		$662K Buy
11,344
+60
+0.5% +$3.43K 0.01% 1007
2015
Q1 		$622K Buy
11,284
+323
+3% +$17.5K 0.01% 1198
2014
Q4 		$550K Buy
10,961
+553
+5% +$27.1K 0.01% 1255
2014
Q3 		$481K Buy
10,408
+439
+4% +$19.8K 0.01% 1314
2014
Q2 		$436K Buy
9,969
+105
+1% +$4.25K 0.01% 1337
2014
Q1 		$411K Buy
9,864
+2,362
+31% +$101K 0.01% 1257
2013
Q4 		$278K Buy
7,502
+185
+3% +$6.63K 0.01% 1489
2013
Q3 		$257K Buy
+7,317
New +$242K 0.01% 1450

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Janney Montgomery Scott's PBE Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 9% in Q1 2026, selling an estimated $30.6K and leaving 3,830 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Janney Montgomery Scott first reported a position in PBE in Q3 2013 and has held it in 50 quarters since. The position peaked at $969K in Q1 2019. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Janney Montgomery Scott held 3,830 shares of Invesco Biotechnology & Genome ETF worth $303K as of Q1 2026.
  • Janney Montgomery Scott sold 378 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $30.6K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2376 holding.
  • Janney Montgomery Scott first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and has held it in 50 quarters since.
  • Janney Montgomery Scott's Invesco Biotechnology & Genome ETF position peaked at $969K in Q1 2019.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.